determining the optimal dose of induction therapy for patients with aml
Published 1 year ago • 94 plays • Length 5:22Download video MP4
Download video MP3
Similar videos
-
3:16
the optimization of induction chemotherapy for patients with aml
-
3:14
determining the optimal frontline treatment of aml
-
2:07
the importance of induction chemotherapy in the aml treatment
-
0:45
optimizing chemotherapy combinations for aml
-
1:09
menin inhibitors for the treatment of aml: insights into the covalent-101 trial
-
1:04
clad-ldac-ven induction therapy in aml: insights from a phase ii trial
-
2:09
advances in the management of fit adults with aml
-
1:33
the current guidelines and therapies for tp53-mutated mds and aml
-
2:45
continuity of care for patients with hematological predispositions to aml
-
0:53
an overview of optimal sequencing therapy in aml
-
10:34
remission induction therapy prior to allosct in aml: insights from the asap trial
-
1:39
optimizing chemotherapy in aml
-
5:16
single versus double induction with 7 3 for newly diagnosed aml
-
1:37
a phase ii trial evaluating e7820 in patients with aml with splicing factor mutations
-
1:05
the importance of using mrd to guide treatment decisions in all
-
4:22
the role of mrd in aml
-
1:32
methods to evaluate mrd in aml
-
3:21
a phase i trial of hu8f4, an anti-pr1/hla-a2 monoclonal antibody, in r/r myeloid malignancies